Literature DB >> 76

Multiple forms of casein kinase from rabbit erythrocytes.

R Kumar, M Tao.   

Abstract

Two rabbit erythrocyte casein kinases, GTP:casein kinase I and GTP:casein kinase II, have been purified 29 000- and 47 000-fold, respectively. Studies employing sucrose density gradient centrifugation indicate that kinase I has a molecular weight of about 9.5 - 10(5) (25 S) and kinase II about 1.4 - 10(6) (32 S). These enzymes can utilize either ATP or GTP as the phosphoryl donor. Among various protein substrates examined, these kinases catalyze the phosphorylation of casein greater than 50% dephosphorylated phosvitin congruent to 50% dephosphorylated casein greater than phosvitin. Histones, protamine and bovine serum albumin are poor phosphoryl acceptors. Kinetic data indicate that both enzymes are inhibited by high casein substrate concentrations which may be partially relieved by NaCl. Both phosphotransferases require Mg(2+) for activity and are optimally active at pH 9.0. The enzymes have apparent Km values of 2.5 - 10(-5) M for GTP, 2 - 10(-5) M for ATP, and 0.4--0.6 mg/ml for casein. The incorporation of the terminal phosphate of GTP into casein as catalyzed by these enzymes is inhibited to varying degrees by ATP, ITP, ADP, and GDP but not by UTP, CTP, GMP, adenosine 3':5'-cyclic monophosphate, and guanosine 3':5'-cyclic monophosphate. In addition, NaF and 2,3-diphosphoglyceric acid are also found to inhibit the activity of both kinases. The effect of 2,3-diphosphoglycerate is interesting and suggests that this metabolite may regulate the activity of the casein kinases in the red blood cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 76     DOI: 10.1016/0005-2744(75)90209-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Cystic fibrosis in Jews: frequency and mutation distribution.

Authors:  B Kerem; O Chiba-Falek; E Kerem
Journal:  Genet Test       Date:  1997

2.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 3.  Genotype and phenotype in cystic fibrosis.

Authors:  J Zielenski
Journal:  Respiration       Date:  2000       Impact factor: 3.580

4.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Authors:  Bonnie W Ramsey; Jane Davies; N Gerard McElvaney; Elizabeth Tullis; Scott C Bell; Pavel Dřevínek; Matthias Griese; Edward F McKone; Claire E Wainwright; Michael W Konstan; Richard Moss; Felix Ratjen; Isabelle Sermet-Gaudelus; Steven M Rowe; Qunming Dong; Sally Rodriguez; Karl Yen; Claudia Ordoñez; J Stuart Elborn
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

5.  Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.

Authors:  M Wilschanski; J Zielenski; D Markiewicz; L C Tsui; M Corey; H Levison; P R Durie
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

6.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770.

Authors:  Fredrick Van Goor; Sabine Hadida; Peter D J Grootenhuis; Bill Burton; Dong Cao; Tim Neuberger; Amanda Turnbull; Ashvani Singh; John Joubran; Anna Hazlewood; Jinglan Zhou; Jason McCartney; Vijayalaksmi Arumugam; Caroline Decker; Jennifer Yang; Chris Young; Eric R Olson; Jeffery J Wine; Raymond A Frizzell; Melissa Ashlock; Paul Negulescu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

7.  Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  C E Bear; C H Li; N Kartner; R J Bridges; T J Jensen; M Ramjeesingh; J R Riordan
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

8.  Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium.

Authors: 
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

9.  A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.

Authors:  Eric W F W Alton; A Christopher Boyd; Seng H Cheng; Steve Cunningham; Jane C Davies; Deborah R Gill; Uta Griesenbach; Tracy Higgins; Stephen C Hyde; J Alastair Innes; Gordon D Murray; David J Porteous
Journal:  Thorax       Date:  2013-03-22       Impact factor: 9.139

  9 in total
  7 in total

1.  Evidence that insulin activates casein kinase 2 in rat epididymal fat-cells and that this may result in the increased phosphorylation of an acid-soluble 22 kDa protein.

Authors:  T A Diggle; C Schmitz-Peiffer; A C Borthwick; G I Welsh; R M Denton
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

2.  Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3.

Authors:  K Nilsson Ekdahl; B Nilsson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

3.  Phosphorylation of eukaryotic protein synthesis initiation factors.

Authors:  R Benne; J Edman; R R Traut; J W Hershey
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  Mitotic kinase anchoring proteins: the navigators of cell division.

Authors:  Luke J Fulcher; Gopal P Sapkota
Journal:  Cell Cycle       Date:  2020-02-12       Impact factor: 4.534

5.  Serine/threonine phosphorylation regulates binding of C hnRNP proteins to pre-mRNA.

Authors:  S H Mayrand; P Dwen; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  Adenosine 3':5'-cyclic monophosphate-dependence of protein kinase isoenzymes from mouse liver.

Authors:  P M Ueland; S O Doskeland
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

Review 7.  The FAM83 family of proteins: from pseudo-PLDs to anchors for CK1 isoforms.

Authors:  Polyxeni Bozatzi; Gopal P Sapkota
Journal:  Biochem Soc Trans       Date:  2018-06-05       Impact factor: 5.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.